In compliance with the provisions of Regulation 33(3)(b)(i) of SEBI (Listing Obligations and Disclosures Requirements)Regulations, 2015, Biocon has informed that the Company opts to submit quarterly/ year-to-date consolidated financial results in addition to submission of standalone financial results for the financial year 2017-18.
The above information is a part of company’s filings submitted to BSE.